Today: 20 March 2026
CrowdStrike stock jumps nearly 5% after Aramco pact — what investors watch next
7 February 2026
1 min read

CrowdStrike stock jumps nearly 5% after Aramco pact — what investors watch next

NEW YORK, Feb 6, 2026, 19:10 EST — After-hours

  • CrowdStrike finished the day up 4.8% at $395.50, bouncing after a tough stretch for software stocks.
  • The company has signed a non-binding memorandum of understanding with Saudi Arabia’s Aramco.
  • Next up: March 3 results, plus any updates on if—or when—the Aramco talks might actually start bringing in revenue.

CrowdStrike Holdings, Inc. (CRWD) shares jumped 4.8% Friday, holding close to $395 after hours. The cybersecurity company announced it signed a memorandum of understanding with Saudi Aramco. CrowdStrike

CrowdStrike shares broke a seven-day slide with the rebound, but the stock remains around 30% off its 52-week peak, MarketWatch data show. Trading volume jumped—roughly 4.9 million shares changed hands, topping the 50-day average. MarketWatch

Tech stocks snapped back Friday after a rough patch fueled by anxiety over AI-related spending and lofty valuations. The Dow, meanwhile, finished above 50,000 for the first time ever. “There’s real demand for AI products,” a Baird strategist noted, with buyers returning to the sector. Reuters

CrowdStrike described its memorandum of understanding with Aramco as a non-binding agreement aimed at laying the groundwork for broader collaboration on cybersecurity across Saudi Arabia. The plan: build out a “unified, Kingdom-wide security model” to help defend vital infrastructure. CEO George Kurtz put it this way: “We’re proud to collaborate with Aramco as Saudi Arabia accelerates its secure AI adoption.” Business Wire

“Through this relationship, we aim to demonstrate our first-step commitment to supporting the Kingdom’s growth by adopting world-class technologies,” said Ahmad O. Al Khowaiter, Aramco’s Executive Vice President of Technology & Innovation. Nasdaq

Traders want specifics—commercial terms, rollout schedule, and if all this talk actually results in paid work—details missing from the headline MoU. CrowdStrike especially needs a tangible route from “discussions” to signed contracts, coming off that steep drop in software stocks.

Cybersecurity stocks moved higher Friday—Fortinet climbed nearly 4.9%, while Palo Alto Networks saw a gain of about 2.9% for the session, according to MarketWatch data. MarketWatch

CrowdStrike CEO Kurtz offloaded shares this week, a Form 4 filing shows, selling to cover taxes on vested restricted stock units, per remarks in the document. SEC

Another Form 144 popped up, this one flagging a shareholder’s intent to offload 28,853 CrowdStrike shares—totaling roughly $11.9 million by market value. SEC

The Aramco memorandum isn’t a binding contract, and projects that straddle borders and depend on infrastructure often morph or stall. If negotiations drag or pricing and scope stay murky, the stock could find itself once more dependent on broader risk sentiment.

CrowdStrike will post its fourth-quarter and full-year numbers March 3, after the U.S. session wraps up. The company’s conference call kicks off at 5 p.m. Eastern. Investors want to hear about forward guidance, insights on deal flow, and where things stand with the Aramco discussions. finance.yahoo.com

Stock Market Today

  • Regeneus Ltd (RGS.AX) Jumps 33% on Heavy Volume, Signals Short-Term Upside
    March 19, 2026, 10:42 PM EDT. Regeneus Ltd (RGS.AX) surged 33.33% to A$0.012 on March 20, 2026, driven by unusually heavy volume of 4.28 million shares, nearly seven times the average. The stock broke above its 50-day and 200-day moving averages, indicating increased short-term trader interest in this clinical-stage biotech focused on osteoarthritis and wound healing. Despite negative earnings per share and liquidity constraints, the price action reflects momentum trading in a volatile sector. Traders should watch intraday support at A$0.010 and resistance near the year high of A$0.020. With a Meyka AI rating of 64.90 (Grade B), the stock is rated HOLD amid high volatility and thin order books typical of small-cap biotechs on the Australian Securities Exchange (ASX).
Bank of America stock price rises 3% (BAC) as Dow tops 50,000; next catalysts loom
Previous Story

Bank of America stock price rises 3% (BAC) as Dow tops 50,000; next catalysts loom

Applied Materials stock jumps 6% as chip rally returns — what to watch before AMAT earnings
Next Story

Applied Materials stock jumps 6% as chip rally returns — what to watch before AMAT earnings

Go toTop